Co-diagnostics, Inc. · NASDAQ:CODX
Armistice Capital, LLC reported a 9.99% stake in Co-diagnostics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 9.99% stake in Co-diagnostics, Inc., 559,706 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 559,706
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 559,706 |
| Steven Boyd | 9.99% | 559,706 |
Source
Related
- Co-diagnostics, Inc.
- Armistice Capital, LLC
- Co-diagnostics, Inc. shareholders
- Schedule 13G/A · Jane Street Group, LLC · Aug 10, 2026
- Schedule 13G · Jane Street Group, LLC · Jun 3, 2026
- Form 4 · Egan Dwight H · May 27, 2026
- Form 4 · Brown Brian Lee · May 27, 2026
- Form 4 · Abbott Richard David · May 27, 2026